Objectives: The interaction between HIV and COVID-19 resulted in a syndemic that showed an excess burden of disease for people with HIV (PWH). Four years of the COVID-19 pandemic have raised many unsolved questions about the optimal care of COVID-19 in PWH. Methods: We performed a study using a three-round Delphi methodology involving a panel of physicians with expertise in HIV and COVID-19 infections. The main aim of the study was to provide recommendations on critical clinical issues of COVID-19 among PWH and to inform physicians and policy-makers for improving care and prevention of COVID-19 in PWH. A total of 27 questions were conceived, focusing on four main areas of interest in the management of COVID-19 in PWH; a panel of 34 experts in HIV and COVID-19 care expressed their level of agreement on each item. Questions that received agreement/disagreement ≥79.4% of panellists were identified and statements were generated accordingly. Results: Consensus was reached on 19/27 items, resulting in 18 final statements. These statements addressed: (a) risk of COVID-19 progression to severe disease among PWH; (b) COVID-19 diagnostics and laboratory procedures; (c) early treatments with antivirals and/or monoclonal antibodies; (d) use of corticosteroids; (e) COVID-19 preventive strategies. Discussion: This consensus's study guides infectious diseases physicians in making decisions regarding the care of PWH for COVID-19, where results from the scientific literature are limited or conflicting.
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV / A. Tavelli, A. Vergori, A. Cingolani, F. Bai, A.M. Azzini, G.L. Hara, M.G. Caponcello, M. Rinaldi, Z.R. Palacios-Baena, M. Gatti, G. Maccarrone, E. Tacconelli, A. Antinori, A.D. Monforte, J. Berenguer, S. Bhagani, F. Bonnet, S. Bonora, F. Burns, P. De Nardo, L. De Vedia, A. Di Biagio, A. Giacomelli, M. Hentzien, M. Hojman, B. Ole Jensen, G. Lapadula, G.L. Hara, M. Lichtner, G. Marchetti, E. Martinez, V. Mazzotta, C. Paola, M. Parczewski, C.F. Perno, M. Puoti, E. Quiros-Roldan, J. Rockstroh, J.R. Baño, A.H. Elvire Roukens, S. Rusconi, L. Sarmati, S. Savinelli, A. Sönnerborg, O. Sued, M. Van Der Valk, A. Cozzi-Lepri, S. Piconi, L. Pipitò, G. Pellicanò, A. De Vito, F.M. Fusco, M. Augello, R. Esvan, S. Lo Caputo, A. Costantini, D. Marzolla, A. Amicucci, G. Fornaro, A. Toschi, R. Pascale, M. Giannella, B. Tazza, A. Savoldi, E. Gentilotti, L. Lambertenghi, G. Fasani, M.D. Pezzani, M. Conti, M. Mirandola, P. Olivares-Navarro, A. De La Serna, L. Barrera-Pulido, V. Palomo, L. Cubero-Aranda, A. Alemán-Rodríguez, M.I. Sanchez-Gárcia, A.B. Hidalgo-Cespedes, I. Hrom-Hrom, C. Dellacasa, E. Rossi, S. Cataudella. - In: CLINICAL MICROBIOLOGY AND INFECTION. - ISSN 1198-743X. - 31:8 Supplement(2025 Mar 21), pp. S14-S25. [10.1016/j.cmi.2025.03.006]
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV
F. Bai;M. Gatti;A.D. Monforte;S. Bonora;A. Giacomelli;G. Lapadula;G. Marchetti;C.F. Perno;S. Rusconi;S. Piconi;M. Augello;A. Savoldi;M.D. Pezzani;
2025
Abstract
Objectives: The interaction between HIV and COVID-19 resulted in a syndemic that showed an excess burden of disease for people with HIV (PWH). Four years of the COVID-19 pandemic have raised many unsolved questions about the optimal care of COVID-19 in PWH. Methods: We performed a study using a three-round Delphi methodology involving a panel of physicians with expertise in HIV and COVID-19 infections. The main aim of the study was to provide recommendations on critical clinical issues of COVID-19 among PWH and to inform physicians and policy-makers for improving care and prevention of COVID-19 in PWH. A total of 27 questions were conceived, focusing on four main areas of interest in the management of COVID-19 in PWH; a panel of 34 experts in HIV and COVID-19 care expressed their level of agreement on each item. Questions that received agreement/disagreement ≥79.4% of panellists were identified and statements were generated accordingly. Results: Consensus was reached on 19/27 items, resulting in 18 final statements. These statements addressed: (a) risk of COVID-19 progression to severe disease among PWH; (b) COVID-19 diagnostics and laboratory procedures; (c) early treatments with antivirals and/or monoclonal antibodies; (d) use of corticosteroids; (e) COVID-19 preventive strategies. Discussion: This consensus's study guides infectious diseases physicians in making decisions regarding the care of PWH for COVID-19, where results from the scientific literature are limited or conflicting.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1198743X25001247-main(1).pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
373.28 kB
Formato
Adobe PDF
|
373.28 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




